This is a demo store. No orders will be fulfilled.

Cediranib Maleate - 10mM in DMSO, high purity , CAS No.857036-77-2

    Grade & Purity:
  • 10mM in DMSO
In stock
Item Number
C426384
Grouped product items
SKU Size
Availability
Price Qty
C426384-1ml
1ml
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$87.90

VEGFR3 Selective Inhibitors

Basic Description

Synonyms Cediranib maleate | 857036-77-2 | Cediranib (maleate) | AZD-2171 maleate | AZD2171 MALEATE | Cediranib maleat | 68AYS9A614 | 857036-77-2 (maleate) | 4-((4-fluoro-2-methyl-1h-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline maleate | Quinazoline, 4-((4-fl
Specifications & Purity 10mM in DMSO
Biochemical and Physiological Mechanisms Cediranib Maleate (AZD-2171) is the maleate salt of Cediranib, which is a potent inhibitor of VEGFR with IC50 of <1 nM and also inhibits Flt1/4 with IC50 of 5 nM/≤3 nM.
Storage Temp Store at -80°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Product Description

Information

Cediranib Maleate (AZD-2171) is the maleate salt of Cediranib, which is a potent inhibitor ofVEGFRwith IC50 of <1 nM and also inhibits Flt1/4 with IC50 of 5 nM/≤3 nM.

Targets

VEGFR2/KDR (HUVECs); c-Kit (HUVECs); c-Kit (HUVECs); VEGFR3/FLT4 (HUVECs); VEGFR1/FLT1 (HUVECs) 29716,0.5 nM; 2 nM; 2 nM; <=3 nM; 5 nM

In vitro

In recombinant kinase assays, cediranib inhibits VEGFR-1 kinase activity (IC50 = 5 nmol/L) within a similar concentration range to VEGFR-2 and VEGFR-3 (IC50 values of <0.1 and ≤3 nmol/L). It shows selectivity against other kinases. Cediranib has similar potency against c-Kit when compared with VEGFR-2 in phosphorylation assays but less potency against PDGFR-α and PDGFR-β, particularly in a PDGF-AA/PDGFR-α–driven tumor cell proliferation assay. Cediranib is inactive against wild-type Flt-3 (IC50 value >1 μmol/L) and had marginal activity versus FGFR-1 and -4 (IC50 values of 0.35 and 2.17 μmol/L, respectively).

In vivo

Phosphorylation of wild-type c-Kit in NCI-H526 tumor xenografts was reduced markedly following oral administration of cediranib (≥1.5 mg/kg/d) to tumor-bearing nude mice.

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Organic oxygen compounds
Class Organooxygen compounds
Subclass Ethers
Intermediate Tree Nodes Not available
Direct Parent Diarylethers
Alternative Parents Quinazolines  Indoles  Anisoles  Alkyl aryl ethers  Unsaturated fatty acids  Aryl fluorides  Dicarboxylic acids and derivatives  Substituted pyrroles  N-alkylpyrrolidines  Pyrimidines and pyrimidine derivatives  Heteroaromatic compounds  Trialkylamines  Azacyclic compounds  Carboxylic acids  Hydrocarbon derivatives  Carbonyl compounds  Organic oxides  Organofluorides  
Molecular Framework Not available
Substituents Diaryl ether - Quinazoline - Indole - Indole or derivatives - Anisole - Phenol ether - Alkyl aryl ether - Aryl fluoride - Aryl halide - Dicarboxylic acid or derivatives - Fatty acyl - Pyrimidine - Fatty acid - Substituted pyrrole - Unsaturated fatty acid - N-alkylpyrrolidine - Benzenoid - Pyrrolidine - Pyrrole - Heteroaromatic compound - Tertiary aliphatic amine - Tertiary amine - Azacycle - Organoheterocyclic compound - Carboxylic acid derivative - Carboxylic acid - Organonitrogen compound - Organic oxide - Organic nitrogen compound - Amine - Carbonyl group - Hydrocarbon derivative - Organohalogen compound - Organofluoride - Aromatic heteropolycyclic compound
Description This compound belongs to the class of organic compounds known as diarylethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are aryl groups.
External Descriptors Not available

Product Properties

ALogP 1.765
HBD Count 1
Rotatable Bond 10

Names and Identifiers

IUPAC Name (Z)-but-2-enedioic acid;4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline
INCHI InChI=1S/C25H27FN4O3.C4H4O4/c1-16-12-17-19(29-16)6-7-21(24(17)26)33-25-18-13-22(31-2)23(14-20(18)27-15-28-25)32-11-5-10-30-8-3-4-9-30;5-3(6)1-2-4(7)8/h6-7,12-15,29H,3-5,8-11H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-
InChIKey JRMGHBVACUJCRP-BTJKTKAUSA-N
Smiles CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5.C(=CC(=O)O)C(=O)O
Isomeric SMILES CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5.C(=C\C(=O)O)\C(=O)O
PubChem CID 11226834
Molecular Weight 566.58

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Chemical and Physical Properties

Sensitivity moisture sensitive
DMSO(mg / mL) Max Solubility 100
DMSO(mM) Max Solubility 176.497581983127
Water(mg / mL) Max Solubility <1
Molecular Weight 566.600 g/mol
XLogP3
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 11
Rotatable Bond Count 10
Exact Mass 566.218 Da
Monoisotopic Mass 566.218 Da
Topological Polar Surface Area 147.000 Ų
Heavy Atom Count 41
Formal Charge 0
Complexity 743.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 1
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 1
Covalently-Bonded Unit Count 2

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.